MIRA INFORM REPORT

 

 

Report No. :

353536

Report Date :

10.12.2015

 

IDENTIFICATION DETAILS

 

Name :

PLIVA HRVATSKA D.O.O.

 

 

Registered Office :

Lijekova i farmaceutskih proizvoda Prilaz baruna Filipovica 25 HR 10000 Zagreb

 

 

Country :

Croatia

 

 

Financials (as on) :

31.12.2014

 

 

Date of Incorporation :

2003

 

 

Legal Form :

Limited liability company

 

 

Line of Business :

·         Manufacture of pharmaceutical preparations

·         Manufacture of other inorganic basic chemicals

·         Manufacture of other chemical products n.e.c.

·         Technical testing and analysis

·         Other research and experimental development on natural sciences and engineering

·         Manufacture and distribution of pharmaceuticals

·         Research and development of new pharmaceuticals

 

 

No. of Employee :

19857 (2014)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Croatia

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

CROATIA - ECONOMIC OVERVIEW

 

Though still one of the wealthiest of the former Yugoslav republics, Croatia's economy suffered badly during the 1991-95 war. The country's output during that time collapsed, and Croatia missed the early waves of investment in Central and Eastern Europe that followed the fall of the Berlin Wall. Between 2000 and 2007, however, Croatia's economic fortunes began to improve with moderate but steady GDP growth between 4% and 6% led by a rebound in tourism and credit-driven consumer spending. Inflation over the same period remained tame and the currency, the kuna, stable. Croatia experienced an abrupt slowdown in the economy in 2008 and has yet to recover; economic growth was stagnant or negative in each year since 2009. Difficult problems still remain, including a stubbornly high unemployment rate, uneven regional development, and a challenging investment climate. Croatia continues to face reduced foreign investment. On 1 July 2013 Croatia joined the EU, following a decade-long application process. Croatia will be a member of the European Exchange Rate Mechanism until it meets the criteria for joining the Economic and Monetary Union and adopts the euro as its currency. EU accession has increased pressure on the government to reduce Croatia’s relatively high public debt, which triggered the EU’s excessive deficit procedure for fiscal consolidation. Zagreb has cut spending since 2012, and the government also raised additional revenues through more stringent tax collection and by raising the Value Added Tax. The government has also sought to accelerate privatization of non-strategic assets, with mixed success.

 

Source : CIA

 

Company identification

 

PLIVA HRVATSKA d.o.o. za razvoj, proizvodnju i prodaju lijekova i farmaceutskih proizvoda

Phone

+385 1/3720000

Prilaz baruna Filipovica 25

Fax

+385 1/3720111

HR 10000 Zagreb

E-Mail

info@pliva.hr

 

Web

www.pliva.hr

 

Statistic number

1758705

 

 

Short name

PLIVA HRVATSKA d.o.o.

Tax number

44205501677

Company status

active

 

 

 

 

Company summery

 

Legal form         limited liability company

Established       2003.

Registered         2003-09-16, Commercial court Zagreb, MBS: 080469030

last court entry: 2015.10.02

 

According to the decission from 2005.05.25 one part of the company assets is separated and

taken over by the company GLOBALNI SERVISI - IT d.o.o. (MBS: 080506104)

 

According to the court register entry from 2007.06.28 , the company PLIVA ISTRAŽIVANJE I

RAZVOJ d.o.o. (MBS: 080492227) with a legal site in Zagreb, Prilaz baruna Filipovića 29 was

affiliated by transfering its assets to the company PLIVA HRVATSKA d.o.o.

 

According to the court register entry from 2007.12.20 , the company GLOBALNI POSLOVNI

SERVISI-IT d.o.o. (MBS:080506104) with a legal site in Zagreb was affiliated by transfering its

assets to the company PLIVA HRVATSKA d.o.o.

 

According to the court register entry from 2008.11.30, the company PHARMAING d.o.o. (MBS:

080477512) with a legal site in Zagreb, Jagićeva 31, the company PUNCTUM STUDIO d.o.o.

(MBS: 080477711) with a legal site in Zagreb, Gregorčićeva 8 and the company PLIVA-ESOP

d.o.o. (MBS: 080171686) with a legal site in Zagreb, Grada Vukovara 49 were affiliated by

transfering its assets to the company PLIVA HRVATSKA d.o.o.

 

According to the court register entry from 2010.12.31, the company PLIVA Farmaceutika d.d.

(MBS: 080022035) with a legal site in Zagreb, Prilaz baruna Filipovića 25 was affiliated by

transfering its assets to the company PLIVA HRVATSKA d.o.o.

 

According to the court register entry from 2011.05.22, the company TEVA PHARMACEUTICALS

d.o.o. (MBS: 080680817, OIB: 60628553658) with a legal site in Zagreb, Prilaz baruna Filipovića

25 was affiliated by transfering its assets to the company PLIVA HRVATSKA d.o.o.

 

According to the court register entry from 2013.08.02, the company PLIVA ZDRAVLJE d.o.o.

(MBS: 080345413, OIB 68719779759) with a legal site in Zagreb, Prilaz baruna Filipovića 25

was affiliated by transfering its assets to the company PLIVA HRVATSKA d.o.o.

 

Statistic number: 1758705

OIB: 44205501677

 

Establishers      Ivax International B.V.

Computerweg 10, Utrecht, Netherlands                                                                100,00%

 

Basic capital     HRK 3.142.360.000,00

Capital changes:

Until 2003.12.22: HRK 20.000,00

Until 2005.05.25: HRK 3.030.000.000,00

Until 2005.11.02: HRK 3.013.000.000,00

Until 2008.11.30: HRK 3.138.000.000,00

 

Management     Mihael Furjan, president

Trnjanska cesta 37/2, 10000 Zagreb, Croatia

Zoran Bunčić, member, born 1962.06.22

Kuzminečka 6, 10000 Zagreb, Croatia

Nikolina Dizdar Čehulić, member

Ulica Vojina Bakića 1, 10000 Zagreb, Croatia

Romana Šantar, member

Drežnik IV. Odvojak 8 A, 10251 Desprim, Croatia

 

 

Supervisory board          Hubert Puech Pays d Alissac, president

Rue de la Gagnerie 34, 37540 St cyr sur Loire, France

 

Eric Drape, vice-president

6 rue des Reservoirs, Chartres, France

 

Pasquale Vitagliani, member

1-pal. U10-Centro Direzionale Milanofiori Nord-20090-Assago, 1-pal. U10-Centro Direzionale,

Italy

 

Activity                          Manufacture of pharmaceutical preparations

Manufacture of other inorganic basic chemicals

Manufacture of other chemical products n.e.c.

Technical testing and analysis

Other research and experimental development on natural sciences and engineering

Manufacture and distribution of pharmaceuticals

Research and development of new pharmaceuticals

After taking over production and distribution from PLIVA d.d., PLIVA HRVATSKA became the

largest pharmaceutical company and biggest exporter in Croatia

Exports all over the world: Belarus, Czech Republic, Germany, Switzerland, France, Great

 

Britan, Italy, Hungary, Macedonia, Bosnia and Hercegovina, Slovenia, USA

Brands: Andol, Andol 100, Atrocam, Betrion, Cilazil, Diklonat, Gastal, Geokorton, Geonistin, Heptanon, Homofan, Homolong, Homorap, Izosan, Ketocef, Klavocin, Mirocef, Novocef, Oikamid, Peptoran, Phemiton, Plibex, Plivadial, Plivadon, Plivasept, Plivit C, Sinersul, Sumamed, Supremin, Zinidil, Tonocardin, Ulzol, Aviomarin, Diaspam, Enerbol, Flegamina, Hepatil, Lecitan, Sedamin, Venotrex, Mukolina

 

legal site and business premises (production facilities) are located at the above address

facilities in Savski Marof, Prudnička cesta 54

business units:

- Dubrovačka 6, 51000 Rijeka

- Dražanac 72, 21000 Split

- Sjenjak 58, 31000 Osijek

former company address was till 2009-11-16 at Ulica grada Vukovara 49, 10000 Zagreb

 

the company owns vehicles, number and type not known

Book value of vehicles 2014.12.31: HRK 1.460.042,00

 

Basic activity code (according to NACE Rev.2):

Manufacture of pharmaceutical preparations (21.20)

 

Staff 2010                      1914 employees

2011 1745 employees

2012 1783 employees

2013 1897 employees

2014 1957 employees

 

Total revenue                 2010 HRK 2.795.442.600

2011 HRK 2.760.460.300

2012 HRK 3.316.678.770

2013 HRK 3.097.640.280

2014 HRK 3.798.516.810

 

Real estate                    the company owns real estates

Book value of ground 2014.12.31: HRK 117.950.983,00

Book value of buildings 2014.12.31: HRK 916.636.349,00

information about eventual mortgage existance not available

insight into real estate register not possible

 

 

Financial Statement

 

Assets  Currency: HRK ( x 1.000 )        

 

2014.12.31       

2013.12.31

2012.12.31

FIXED ASSETS

5.114.928

4.790.624

4.323.932

Intangible assets

44.245

39.958

39.459

Tangible assets

2.632.707

2.400.305

2.035.347

- land and woods

117.951

248.339

248.339

- buildings

916.636

894.332

851.659

- plants and machinery

696.564

492.897

329.595

- tools, equipment, vehicles

11.891

9.209

9.530

- advance payments for tang. assets

18.632

84.969

136.921

- tangible assets in preparement

827.335

669.963

458.713

- other tangible assets

43.697

596

589

Long term financ. assets

1.737.905

1.702.863

1.701.197

- shares in associated companies

215.551

215.551

215.576

- other participations

91.752

56.198

51.611

- credits, deposits, guarantees

7.274

7.786

9.124

- other financial assets

1.423.328

1.423.328

1.424.886

Long term receivables

700.072

647.498

547.930

CURRENT ASSETS

3.785.899

3.094.640

3.540.097

Inventories

996.290

917.422

973.326

- raw and auxiliary materials

408.816

336.906

495.640

- goods in course of production

158.747

201.380

153.240

- trade goods

150.761

124.452

96.897

- finished products

277.487

251.719

225.769

- advance payments

480

2.965

1.781

Short term receivables

1.374.776

1.298.925

1.579.725

- from associated companies

660.878

493.766

566.820

- from sales

606.280

733.160

773.954

- from staff

2.336

1.152

7.089

- from state and institutions

93.132

69.327

221.140

- others

12.150

1.520

10.721

Short term financial assets

1.345.067

829.450

688.160

Cash at bank and in hand

69.765

48.843

298.886

ACCRUALS

10.177

6.870

7.243

TOTAL ASSETS

8.911.005

7.892.133

7.871.273

 

Liabilities

 

Currency: HRK ( x 1.000 )

2014.12.31

2013.12.31

2012.12.31

EQUITY

4.085.587

4.186.784

3.744.608

Subscribed capital

3.142.360

3.142.360

3.142.360

Reserves

1.128.749

1.742.737

1.736.422

Loss brought forward

771.572

1.134.160

1.810.858

Profit of the period

586.051

435.846

676.684

PROVISIONS

10.292

9.123

7.938

LONG TERM LIABILITIES

3.744.682

2.821.173

2.787.228

SHORT TERM LIABILITIES

795.485

625.792

1.108.028

To associated companies

444.210

373.927

660.336

Deposits, advances payments

161

59

284

To suppliers

316.404

219.432

362.228

To staff

17.949

16.408

15.326

Taxes, fees

15.051

14.419

66.926

Other tax liabilities

0

0

1.285

Other short term liabilities

1.711

1.547

1.643

DEFFERED ITEMS

274.958

249.262

223.471

TOTAL EQUITY AND LIABILITIES

8.911.005

7.892.133

7.871.273

 

 

Profit/loss account

 

Currency: HRK ( x 1.000 )

2014.12.31

2013.12.31

2012.12.31

OPERATING REVENUES

3.656.464

3.075.871

3.130.528

Sales in the country

487.230

514.226

504.169

Sales abroad

2.861.272

2.193.811

2.369.369

Other revenues

307.962

367.833

256.989

OPERATING EXPENSES

2.946.969

2.589.408

2.518.162

Decrease in inventories

147.227

66.325

191.390

Material costs

1.802.023

1.574.248

1.504.156

- raw material costs

885.579

805.039

682.720

- sold goods costs

255.262

252.252

254.238

- other external costs

661.182

516.957

567.198

Staff costs

414.465

381.965

359.441

Depreciation of fixed assets

127.263

108.265

113.224

Depreciation of current assets

21.485

54.952

0

Reserves for expenses and risques

1.170

403

933

Other operating expenses

433.336

403.250

349.019

FINANCIAL REVENUES

142.052

21.770

186.151

FINANCIAL EXPENSES

299.755

171.954

237.376

EXTRAORDINARY REVENUES

0

0

0

EXTRAORDINARY EXPENSES

0

0

0

TOTAL REVENUES

3.798.517

3.097.640

3.316.679

TOTAL EXPENSES

3.246.725

2.761.362

2.755.538

Profit before taxation

551.792

336.278

561.141

Loss before taxation

0

0

0

Taxation on profit

-34.259

-99.568

-115.543

PROFIT OF THE PERIOD

586.051

435.846

676.684

LOSS OF THE PERIOD

0

0

0

 

 

Financial ratios

 

 

2014.12.31

2013.12.31

2012.12.31

Financial stability ratio

1,2830

1,2293

1,2346

Solvency ratio (%)

45,8488

53,0501

47,5731

Debt ratio (in years)

6,3649

6,3350

4,9313

Liquidity ratio

3,5068

3,4791

2,3165

Current ratio

4,7592

4,9452

3,1950

Total assets turnover

0,4263

0,3925

0,4214

Inventories turnover

3,8127

3,3765

3,4076

Collection period (in days)

147,8032

172,6760

197,9096

Creditors Days

34,0168

29,1708

45,3803

Inventories bonding (in days)

94,4223

106,6205

105,6471

Profit margin (%)

15,4284

14,0703

20,4024

Return on total assets (%)

6,5767

5,5225

8,5969

Return on equity (%)

14,3443

10,4100

18,0709

Total revenue per employee (x 1.000)

1.940,9897

1.632,9153

1.860,1676

Profit per employee (x 1.000)

299,4639

229,7554

379,5197

Equity per employee (x 1.000)

2.087,6787

2.207,0552

2.100,1726

Total assets per employee (x 1.000)

4.553,4004

4.160,3234

4.414,6232

Staff costs/Turnover (%)

10,9112

12,3309

10,8374

EBIT (x 1.000)

709.494,9500

486.462,4500

612.365,4300

EBITDA (x 1.000)

858.243,0200

649.679,2500

725.589,1600

EBIT Margin (%)

19,4039

15,8154

19,5611

EBITDA Margin (%)

23,4719

21,1218

23,1779

 

 

Remarks                       2010 import                   HRK     917.405.396,00

2011 import                   HRK     1.349.410.399,00

2012 import                   HRK     1.705.214.215,00

2013 import                   HRK     1.558.424.783,00

2014 import                   HRK     1.732.016.236,00

2010 export                   HRK     1.911.703.953,00

2011 export                   HRK     1.877.567.011,00

2012 export                   HRK     2.369.369.127,00

2013 export                   HRK     2.193.811.319,00

2014 export                   HRK     2.861.272.270,00

2010 profit                     HRK     669.646.330

2011 profit                     HRK     122.385.480

2012 profit                     HRK     561.140.780

2013 profit                     HRK     336.277.790

2014 profit                     HRK     551.792.200

 

 

Subsidiaries

MEDIKA, d.d.

(Statistic number: 3209741) Capraška 1, 10000 Zagreb, Croatia                 25,32%

 

PLIVA d.o.o. Sarajevo

(Statistic number: 4201418590009)

ul. Trg Heroja broj 10, 71120 Sarajevo-Novo Sarajevo,

Bosnia & Hercegovina                                                                            100,00%

 

ASPERA NEKRETNINE d.o.o.

(Statistic number: 2764741)

PRILAZ BARUNA FILIPOVIĆA 25, 10000 ZAGREB, Croatia                      100,00%

 

TEVA Serbia d.o.o.

Republic Serbia                                                                                     100,00%

 

PLIVA SKOPJE d.o.o.e.l.

Macedonia                                                                                            100,00%

 

PLIVA London Ltd.

United Kingdom                                                                                     100,00%

 

TEVA Services Holding Ltd.

Hungary                                                                                                4,32%

 

Short company name: PLIVA HRVATSKA d.o.o.

Translation: PLIVA CROATIA Ltd.

 

Other shares and functions of Mr. Mihael Furjan:

- ASPERA NEKRETNINE d.o.o., Zagreb; president of board

- MEDIKA, d.d., Zagreb; member of supervisory board

 

Investments in:

- 2009: HRK 75.862.293,00

- 2010: HRK 97.523.364,00

- 2011: HRK 175.026.354,00

- 2012: HRK 536.829.075,00

- 2013: HRK 533.321.427,00

- 2014: HRK 527.184.120,00

 

There is no record of payment complaints. Creditreform debt collection department has not handled any case against the company. According to the official information from the Register of transaction accounts, the company accounts are active and are not blocked (date of last check: 2015.12.07).

 

 

Exchange rate:

2010-12-31 EUR 1 = HRK 7,3852

2011-12-31 EUR 1 = HRK 7,5304

2012-12-31 EUR 1 = HRK 7,5456

2013-12-31 EUR 1 = HRK 7,6376

2014-12-31 EUR 1 = HRK 7,6615

 

Inflation:

2010: 1,1%

2011: 2,3%

2012: 3,4%

2013: 2,2%

2014: -0.6%

 

Bankers                        ERSTE&STEIERMÄRKISCHE BANK d.d.

Jadranski trg 3a, 51000 Rijeka, Croatia

HR7924020061100430432

 

RAIFFEISENBANK AUSTRIA d.d.

Petrinjska 59, 10000 Zagreb, Croatia

HR6524840081101874074

 

ZAGREBACKA BANKA d.d.

Paromlinska 2, 10000 Zagreb, Croatia

HR8923600001101683058         

 

 

Payment behaviour

 

Payment behaviour         No complaints,

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.75

UK Pound

1

Rs.100.29

Euro

1

Rs.72.89

HRK

1

Rs.9.60

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

KIN

 

 

Report Prepared by :

TRU

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.